Skip to main content
. Author manuscript; available in PMC: 2014 Dec 17.
Published in final edited form as: Cochrane Database Syst Rev. 2013 Dec 3;12:CD005431. doi: 10.1002/14651858.CD005431.pub3
Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Short-term (5–14 day) visual acuity from 20/20 to 20/40 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Visual acuity between 20/20 and 20/50 at resolution of hyphema 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Time to resolution of primary hemorrhage (days) Other data No numeric data
4 Risk of secondary hemorrhage 2 201 Odds Ratio (M-H, Fixed, 95% CI) 0.61 [0.31, 1.22]
5 Time to rebleed (days) Other data No numeric data
6 Risk of corneal blood stain 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
7 Risk of peripheral anterior synechiae 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
8 Risk of glaucoma or elevated intraocular pressure (IOP) 2 201 Odds Ratio (M-H, Fixed, 95% CI) 0.75 [0.31, 1.81]
9 Duration of hospitalization (days) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected